Top-Tier Executives at Low-Priced Oncology Drug Development Company Buy Shares
Two well-informed and influential executives at Champions Oncology Inc. (NASDAQ:CSBR) purchased shares last week. To start with, President Ronnie Morris purchased three blocks of 10,000 shares each on Friday at prices varying from $1.64 to $1.68 per share. Dr. Morris purchased an additional 10,000-share block on Wednesday for $1.70 apiece. Following the recent string of purchases, the President currently owns 1.11 million shares of Champions Oncology. Chief Executive Officer Joel Ackerman bought 2,000 shares last Monday at a weighted average cost of $1.70 per share. According to the latest Form 4 filing, the CEO of the oncology drug development company holds an ownership stake of 1.04 million shares.
Champions Oncology Inc. (NASDAQ:CSBR) develops and markets advanced technology solutions and products used in the development and use of oncology drugs. Specifically, the company’s TumorGraft Technology Platform offers a novel approach to simulating the results of human clinical trials used in developing oncology drugs. This platform is said to be able to facilitate drug discovery with lower costs and increased speed of drug development. The company reported revenue of $3.7 million for the fiscal quarter ended July 31, significantly above the revenue guidance of $3.25 million to $3.5 million. Champions Oncology has seen the value of its shares plunge by 54% this year. Hal Mintz’s Sabby Capital had around 547,000 shares of Champions Oncology Inc. (NASDAQ:CSBR) in its equity portfolio at the end of the June quarter.
Follow Champions Oncology Inc. (NASDAQ:CSBR)
Follow Champions Oncology Inc. (NASDAQ:CSBR)
Newly-Appointed Executive at Multi-State Bank Holding Company Purchases Shares
One member of American National BankShares Inc. (NASDAQ:AMNB)’s executive team piled up some shares this week. Ramsey K. Hamadi, Executive Vice President since July 2016, acquired 2,000 shares on Monday at $27.16 apiece. After the Monday purchase, Mr. Hamadi currently owns 6,110 shares.
The multi-state bank holding company with total assets of $1.6 billion has seen its market capitalization jump by 6% since the start of the year. American National BankShares Inc. (NASDAQ:AMNB) operates as the holding company for American National Bank, a community bank serving Virginia and North Carolina with 25 banking offices and two loan production offices. The company also manages an additional $780 million of trust, investment and brokerage assets via its Trust and Investment Services Division. The bank holding company reported net income of $3.96 million for the quarter that ended September 30, down from $4.04 million posted a year ago. Jim Simons’ Renaissance Technologies LLC reported ownership of 75,100 shares of American National BankShares Inc. (NASDAQ:AMNB) through its 13F filing for the second quarter.
Follow American National Bankshares Inc. (NASDAQ:AMNB)
Follow American National Bankshares Inc. (NASDAQ:AMNB)
The final page of this article will discuss fresh insider selling at two well-known companies.